Elicera Therapeutics AB
ELIC | FN
Overview
Corporate Details
- ISIN(s):
- SE0015382080 (+1 more)
- LEI:
- 549300I35L0R4INBFG27
- Country:
- Sweden
- Address:
- C/O Elicera Therapeutics AB, 402 24 Göteborg
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Elicera Therapeutics AB develops immuno-oncology therapies based on CAR T-cell technology. They target various cancer indications.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Margareth Jorvid | Other | Other | 21,700 | 40,145.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749703674&Signature=GKSMd-t7fpsQT0QYy22IgzSWEa3M2ubp0CONwt2cXuxqj2KQHz0wYLTHlhsVcbcbqpyPCh5rCXlnh1ouBye3n~C8Xoshd6QpAFtj~CJR6glpRFMUhkPlJ1x~xxKCc1gbj~7oi0k-~sm9MSqOrgSJwKynFuejmqahJlYaIDxNVq1kV0dCtwqUhEDG9ZKA5YfoU9M-SbzRBHLFlcC9l-u2apQKsm6CYNaISRXxVPYm4pPg0PL1da7mUUozPy-Lw9GNsZ1Yx-8SGm1UFB11-DndGTdVqzbUrlqZQvLZs4UkRCln-iOrQRZc5q3ZoGl8jFkaJvAFVYLCIyKKbwaLXCQ2Tw__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA | ||
|
Double Bond Pharmaceutical International AB | Sweden | DBP B |